WallStSmart
VMD

Viemed Healthcare Inc

NASDAQ: VMD · HEALTHCARE · MEDICAL DEVICES

$9.96
+0.71% today

Updated 2026-04-30

Market cap
$380.22M
P/E ratio
26.70
P/S ratio
1.41x
EPS (TTM)
$0.37
Dividend yield
52W range
$6 – $10
Volume
0.3M

Viemed Healthcare Inc (VMD) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-2.0%
Last 4 quarters
Revenue YoY growth
+25.5%
Most recent quarter
EPS YoY growth
+34.5%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-3.3%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-4.3%
2025-11-05
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-10$0.14+7.7%$9.29$9.08-2.3%
2025-11-05$0.09-10.0%$6.54$6.26-4.3%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$0.13$0.14+7.7%$76.18M+25.5%
2025-09-30$0.10$0.09-10.0%$71.91M+24.0%
2025-06-30$0.09$0.08-5.9%$63.06M+14.7%
2025-03-31$0.06$0.06+0.0%$59.13M+16.9%
2024-12-31$0.10$0.10+4.1%$60.70M+19.6%
2024-09-30$0.07$0.10+42.9%$58.00M+17.4%
2024-06-30$0.07$0.04-42.9%$54.97M+26.9%
2024-03-31$0.07$0.04-42.9%$50.59M+27.9%
2023-12-31$0.10$0.09-10.0%$50.74M
2023-09-30$0.09$0.07-22.2%$49.40M
2023-06-30$0.05$0.06+20.0%$43.31M
2023-03-31$0.04$0.04+0.0%$39.56M

Frequently asked questions

Has Viemed Healthcare Inc beaten earnings estimates?
Viemed Healthcare Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -2.0% over the last 4 quarters.
How does VMD stock react to earnings?
VMD stock has moved an average of -3.3% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Viemed Healthcare Inc's revenue growth rate?
Viemed Healthcare Inc reported year-over-year revenue growth of +25.5% in its most recent quarter, with EPS growing +34.5% year-over-year.